ProfileGDS4459 / ENSG00000177463
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 71% 73% 80% 76% 71% 70% 76% 84% 79% 81% 72% 74% 82% 53% 77% 55% 59% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 15.2971
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 25.3873
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 36.2480
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 45.5676
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 55.3971
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 65.370
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 75.8376
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 86.5684
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 96.179
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 106.2481
GSM623474group B, liver allograft wedge biopsie placebo treatment 15.3672
GSM623475group B, liver allograft wedge biopsie placebo treatment 25.7574
GSM623476group B, liver allograft wedge biopsie placebo treatment 36.2882
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.5353
GSM623478group B, liver allograft wedge biopsie placebo treatment 56.0377
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.5755
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.6859